Search research articles
Contact Us
Filters
Showing results (61-70 of 85) with videos related to
Page
of 9
Sort By:
Clinical and Experimental Immunology
|
August 8, 2002
Longitudinal analysis of the T-cell receptor (TCR)-VA and -VB repertoire in CD8+ T cells from individuals immunized with recombinant hepatitis B surface antigen
H Höhn, C Neukirch, K Freitag, et al.
Cancer Research
|
August 1, 1985
Differential gamma-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth
K Pfizenmaier, H Bartsch, P Scheurich, et al.
Cancer Research
|
April 15, 1996
Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression
B Seliger, A Hohne, A Knuth, et al.
Advances in Cancer Research
|
October 11, 2002
Cellular immunity to the Her-2/neu protooncogene
Rolf Kiessling, W Z Wei, F Herrmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 21, 2001
Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule
A Hombach, A Wieczarkowiecz, T Marquardt, et al.
Cancer Research
|
March 31, 2001
T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis
A Hombach, D Sent, C Schneider, et al.
Oncogene
|
March 16, 1995
Induction of platelet-derived growth factor B/c-sis by the v-erbA oncogene in glial cells
T Iglesias, S Llanos, M López-Barahona, et al.
Tissue Antigens
|
March 24, 1998
Development and characterization of mouse anti-human LMP2, LMP7, TAP1 and TAP2 monoclonal antibodies
R Kishore, D J Hicklin, D V Dellaratta, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 24, 1999
CD4+ tumor-infiltrating lymphocytes in cervical cancer recognize HLA-DR-restricted peptides provided by human papillomavirus-E7
H Höhn, H Pilch, S Günzel, et al.
Cancer Research
|
April 15, 1991
Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo
A J Ekstrand, C D James, W K Cavenee, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 85) with videos related to
Sort By:
Page
of 9
Clinical and Experimental Immunology
|
August 8, 2002
Longitudinal analysis of the T-cell receptor (TCR)-VA and -VB repertoire in CD8+ T cells from individuals immunized with recombinant hepatitis B surface antigen
H Höhn, C Neukirch, K Freitag, et al.
Cancer Research
|
August 1, 1985
Differential gamma-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth
K Pfizenmaier, H Bartsch, P Scheurich, et al.
Cancer Research
|
April 15, 1996
Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression
B Seliger, A Hohne, A Knuth, et al.
Advances in Cancer Research
|
October 11, 2002
Cellular immunity to the Her-2/neu protooncogene
Rolf Kiessling, W Z Wei, F Herrmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 21, 2001
Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule
A Hombach, A Wieczarkowiecz, T Marquardt, et al.
Cancer Research
|
March 31, 2001
T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis
A Hombach, D Sent, C Schneider, et al.
Oncogene
|
March 16, 1995
Induction of platelet-derived growth factor B/c-sis by the v-erbA oncogene in glial cells
T Iglesias, S Llanos, M López-Barahona, et al.
Tissue Antigens
|
March 24, 1998
Development and characterization of mouse anti-human LMP2, LMP7, TAP1 and TAP2 monoclonal antibodies
R Kishore, D J Hicklin, D V Dellaratta, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 24, 1999
CD4+ tumor-infiltrating lymphocytes in cervical cancer recognize HLA-DR-restricted peptides provided by human papillomavirus-E7
H Höhn, H Pilch, S Günzel, et al.
Cancer Research
|
April 15, 1991
Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo
A J Ekstrand, C D James, W K Cavenee, et al.
Page
of 9